GlassScriptPhysician profile
Caitlin Dacey Stuber
NPI 1558715458
$33,073.10
in general payments reported to CMS, 2019-2025
8 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what 88% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27K · 2021: $398 · 2022: $3,091 · 2023: $776 · 2024: $555 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,439.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $20,019.26 | 2020 | |
| Abbott Laboratories | $6,610.83 | 2020-2024 | Axium |
| Boston Scientific Corporation | $3,449.33 | 2020-2025 | General - Pain Management, Intracept |
| Medtronic, INC. | $2,334.54 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Spr Therapeutics, INC | $373.02 | 2022-2024 | Sprint Pns System |
| Nevro Corp. | $178.94 | 2021-2022 | |
| Vertos Medical, INC. | $54.68 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $52.50 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Stuber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.